-
COMPARATIVE EFFICACY, SAFETY, AND NETWORK META-ANALYSIS FEASIBILITY OF IMMUNOTHERAPY-BASED COMBINATION THERAPIES FOR ADVANCED RENAL CELL CARCINOMA: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
REPORTING OF ARTIFICIAL INTELLIGENCE (AI) USE IN NICE CLINICAL GUIDELINES AND TECHNOLOGY APPRAISALS: A STRUCTURED REVIEW
Aug 11, 2026, 17:16 PM -
A HYBRID, MULTI-SOURCE REAL-WORLD EVIDENCE FRAMEWORK FOR POST-AUTHORIZATION STUDIES: DESIGN CONSIDERATIONS FOR EU JOINT CLINICAL ASSESSMENT READINESS
Aug 11, 2026, 17:16 PM -
NAVIGATING UNCERTAINTY IN ONCOLOGY: CONCORDANCE BETWEEN EUROPEAN HTA BODIES AND THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Aug 11, 2026, 17:16 PM -
OUTCOMES-BASED AGREEMENTS IN EUROPEAN HTA: NOT A ROUTINE UNCERTAINTY TOOL, BUT A SELECTIVE ACCESS MECHANISM
Aug 11, 2026, 17:16 PM -
A GLOBAL MODELING FRAMEWORK TO ESTIMATE THE LONG-TERM HEALTH AND ECONOMIC RETURNS OF CHILDHOOD OBESITY PREVENTION INITIATIVES ACROSS MULTIPLE COUNTRIES
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE DISEASE BURDEN OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER (LA/MUC) USING A DISABILITY-ADJUSTED LIFE-YEARS (DALYS) ESTIMATION APPROACH: FINDINGS FROM A RETROSPECTIVE OBSERVATIONAL STUDY IN SWEDEN
Aug 11, 2026, 17:16 PM -
IMPORTANCE OF SCREENING EXAMINATIONS FOR SEXUALLY TRANSMITTED DISEASES AMONG INTERNATIONAL STUDENTS
Aug 11, 2026, 17:16 PM -
GLOBAL BURDEN AND TEMPORAL TRENDS OF KNEE OSTEOARTHRITIS: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY
Aug 11, 2026, 17:16 PM -
AI-SUPPORTED REIMBURSEMENT COMMUNICATION FOR PHARMACEUTICAL SALES TEAMS: A REAL-WORLD IMPLEMENTATION BY MARS AND HEALTHMIND
Aug 11, 2026, 17:16 PM -
WHEN IS IT SAFE FOR MEN AGED =65 YEARS WITH AN ABDOMINAL AORTIC ANEURYSM (AAA) TO EXIT FROM SCREENING? AN EVIDENCE MAP AND SUBSEQUENT RAPID REVIEW
Aug 11, 2026, 17:16 PM -
HOW MANY PATIENTS DOES A MICROSIMULATION NEED? CONVERGENCE IN PATIENT-LEVEL SIMULATION, AND THE DIMINISHING MARGINAL BENEFIT OF SIZE
Aug 11, 2026, 17:16 PM -
THE GLOBAL RIPPLE EFFECT OF US DRUG PRICING REFORMS: MANUFACTURER STRATEGIES, PAYER COUNTER-OFFENSIVES, AND HEOR TRANSFORMATION EX-US
Aug 11, 2026, 17:16 PM -
TEPROTUMUMAB FOR THYROID EYE DISEASE: UK KEY OPINION LEADER PERSPECTIVES TO INFORM A NICE HTA STRATEGY
Aug 11, 2026, 17:16 PM -
CAREGIVER IMPACTS OF ACUTE AND CHRONIC MIGRAINE: A LITERATURE-BASED CONCEPTUAL MODEL
Aug 11, 2026, 17:16 PM -
PATIENT-LEVEL SIMULATIONS IN NICE TECHNOLOGY APPRAISALS: HOW OFTEN ARE THEY USED AND WHY ARE THEY CHOSEN?
Aug 11, 2026, 17:16 PM -
MEASUREMENT PROPERTIES OF THE PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD): A GLOBAL STUDY OF PATIENTS WITH ALOPECIA AREATA
Aug 11, 2026, 17:16 PM -
ESTABLISHING NON-INFERIORITY OF RITUXIMAB PLUS LENALIDOMIDE IN THE TREATMENT OF ADVANCED PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA
Aug 11, 2026, 17:16 PM -
FIVE-YEAR BLOOD PRESSURE TRAJECTORIES AND CUMULATIVE RISK OF SEVERELY UNCONTROLLED HYPERTENSION IN 67764 HYPERTENSIVE PATIENTS
Aug 11, 2026, 17:16 PM -
HERNIA RISK, DEPRIVATION AND FAIRER PREVENTION
Aug 11, 2026, 17:16 PM
